Menu Search
Equities

Aflac Inc

AFL:FRA

Aflac Inc

Actions
  • Price (EUR)31.00
  • Today's Change-2.94 / -8.66%
  • Shares traded3.00
  • 1 Year change-29.74%
  • Beta0.8912
Data delayed at least 15 minutes, as of Mar 27 2020 13:30 BST.
More ▼

Profile data is unavailable for this security.

About the company

Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.

  • Revenue in USD (TTM)22.34bn
  • Net income in USD3.30bn
  • Incorporated1973
  • Employees10.98k
  • Location
    Aflac Inc1932 WYNNTON RDCOLUMBUS 31999United StatesUSA
  • Phone+1 (706) 323-3431
  • Fax+1 (706) 324-6330
  • Websitehttps://www.aflac.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		AFL:NYQ since
announced		Transaction
value
Argus Holdings LLCDeal completed12 Jul 201912 Jul 2019Deal completed-37.19%96.00m
Data delayed at least 15 minutes, as of Mar 27 2020 22:30 BST.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.